About Us Team Pipeline News Contact Us Careers Home

Charles E. Lannon Appointed as Vice-Chairman of the Board at Kinex Pharmaceuticals

Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer

Pharmaceutical Industry Veteran is Appointed CMO at Kinex Pharmaceuticals

Kinex Completes Round of Financing

Kinex Phase 1 Clinical Data Selected as "Best of ASCO"

More headlines ...

Pipeline

Kinex will develop its current leads and leverage its technology platform to build a pipeline of clinical candidates that address large market opportunities and unmet medical needs.

Programs         Target Indication Discovery Research Pre-Clinical Clinical Trials Src Cancer Src Hearing Loss     LCK Immunology       ZAP70 Arthritis       FAK Opthalmic Disease     JAK Inflammation

©2010 Kinex Pharmaceuticals. All rights reserved.